FGF23, alpha-Klotho and vitamin D mediated calcium-phosphate metabolism in haemodialysis patients
Open Access
- 1 January 2021
- journal article
- research article
- Published by Centre for Evaluation in Education and Science (CEON/CEES) in Journal of Medical Biochemistry
- Vol. 40 (2) , 160-166
Abstract
Background: Klotho is a protein that acts as a co-receptor for FGF23. FGF23-Klotho axis has great importance regarding to the regulation of mineral metabolism by kidneys. In this study, we analyzed FGF23, αKlotho, 1,25-dihydroxyvitamin D3, 25-hydroxyvitamin D, parathormone, calcium and phosphate levels of hemodialysis patients in order to investigate the nature of the mineral metabolism disruption in chronic kidney diseases. Methods: Sixty hemodialysis patients and 34 healthy controls were included in the study. Serum iFGF, cFGF, soluble αKlotho were analyzed using ELISA kits. 1,25-dihydroxyvitamin D3 was determined using LC-MS/MS. Calcium, phosphate, iPTH and 25-hydroxyvitamin D were measured using autoanalyzers. Results: In hemodialysis patients, iFGF23, cFGF23, iPTH and P levels were significantly higher and 1,25-dihydroxyvitamin D3, αKlotho and Ca levels were significantly lower compared with the control group. There was no significant difference in 25-hydroxyvitamin D levels. Conclusion: Our study showed that lack of sufficient amounts of αKlotho is crucial for mineral metabolism disruptions seen as a complication of chronic kidney diseases. Despite the high levels of the hormone, FGF23 is unable to accomplish its function properly, likely due to deteriorated kidney function in hemodialysis patients.Keywords
This publication has 25 references indexed in Scilit:
- Association between Circulating Fibroblast Growth Factor 23, α-Klotho, and the Left Ventricular Ejection Fraction and Left Ventricular Mass in Cardiology InpatientsPLOS ONE, 2013
- Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney diseaseKidney International, 2011
- Serum Phosphate and Mortality in Patients with Chronic Kidney DiseaseClinical Journal of the American Society of Nephrology, 2010
- Clinical relevance of FGF-23 in chronic kidney diseaseKidney International, 2009
- Human PTH gene regulation in vivo using transgenic miceAmerican Journal of Physiology-Renal Physiology, 2009
- Improving Global Outcomes in Mineral and Bone DisordersClinical Journal of the American Society of Nephrology, 2008
- The emerging role of the fibroblast growth factor-23–klotho axis in renal regulation of phosphate homeostasisJournal of Endocrinology, 2007
- Klotho converts canonical FGF receptor into a specific receptor for FGF23Nature, 2006
- Severely Reduced Production of Klotho in Human Chronic Renal Failure KidneyBiochemical and Biophysical Research Communications, 2001
- The renal phosphate transport defect in normal mice parabiosed to X-linked hypophosphatemic mice persists after parathyroidectomyJournal of Bone and Mineral Research, 1989